腹部手术患者围术期进行膳食纤维补充对术后胃肠道不良反应的系统评价及Meta分析

表1 纳入系统评价的研究特征

研究	国家	样本量(EG:CG)	手术类型	干预措施
				疗程和剂量	纤维种类
Gianotti et al, 2002[17]	Italy	305(203:102)	Gastroesophageal/Pancreatic/Colorectal resections	术前10 g/d×5 d	PHGG(Oral Impact)
				术前10 g/d×5 d; 术后15 g/d
Rayes et al, 2002[19]	German Sweden	90(30:60)	Elective laparotomy and resection of the liver, stomach, colon or pancreas	术后11.3 g/(L·d)×4 d	燕麦纤维+乳酸菌; 燕麦纤维+热杀乳酸菌
Homann et al, 2004[18]	German	100(50:50)	Upper gastrointestinal surgery	术前20 g/(L·d)×5-10 d	PHGG
Xu et al, 2006[21]	China	60(30:30)	Radical gastrectomy/colectomy/proctocolectomy	术前10 g/d×7 d	PHGG(Oral Impact)
Finco et al, 2007[15]	Italy	28(14:14)	Laparoscopic colorectal surgery	术前7.5 g/d×6 d; 术后7.5 g/d×3 d	PHGG(Oral Impact)
Xu et al, 2016[22]	China	60(30:30)	Colon cancer with surgery	术后25 g/d×7 d	可溶性膳食纤维(Beijing yikang Biotechnology Corp)
Seguin et al, 2016[20]	France	35(18:17)	Hepatectomy	术前9 g/d×7 d; 术后9 g/d×3 d	PHGG(Oral Impact, Sachet of powder)
Gade et al, 2016[16]	Denmark	35(19:16)	Pancreaticoduodenectomy, total/distal pancreatectomy, surgical palliation	术前12 g/d×7 d	PHGG(Oral Impact, Sachet of powder)
Zhao et al, 2017[23]	China	120(40:80)	Gastrectomy	术后27 g/d×7 d	溶性膳食纤维(Shen Jia, Beijing yikang Biotechnology Corp); 可溶性纤维+益生菌

PHGG: 部分水解瓜尔胶; EG: 膳食纤维补充组; CG: 对照组.